What was the average cost to bring one drug to market in 2005?

Study for the Clinical Research and Ethical Considerations Test. Enhance your understanding with multiple choice questions covering essential ethical guidelines and research methodologies. Prepare effectively for your test!

The main idea is that developing a new drug is extremely costly due to a long, risky process and the need to cover failed attempts as well as successful ones. In 2005, widely cited analyses from the Tufts Center for the Study of Drug Development estimated that the average cost to bring a single new drug to market was about $1.3 billion when including the cost of capital and the expenses from failed candidates. This figure accounts for everything from discovery and preclinical work through multiple clinical trial phases and regulatory approval, plus post‑market monitoring, spread across the few drugs that actually succeed. The other options are either higher estimates that arise from different methodologies or broader definitions, or much too low to capture the full scope of a typical development program. So, the $1.32 billion figure reflects the best-supported 2005 estimate.